This activation also results in degradation of the erythroid transcription factor GATA1, through caspase-1 activation [40], changing the ratio between GATA1 and the myeloid transcription factor PU.1 favoring myeloid commitment, maturation arrest, and anemia [40,41]. The gene discussed is SPI1; the disease is anemia.